CN101200767A - Method for detecting peripheral blood specific T lymphocyte - Google Patents

Abstract

A method used for detecting peripheral blood clone specific T lymphocytes includes: extracting total RNA of peripheral blood mononuclear cells and being transcribed to cDNA; designing upstream primers and common downstream primers of 24 families in T cell receptor Beta chain variable region (TCRBV); using a dye method (SYBRGreenI) to implement fluorescence quantitative PRC amplification cDNA; analyzing PCR products according to a melting curve and drawing a map for the negative first derivative (-dF/dT) of the fluorescence intensity change of the PCR products and the temperature (Tm) to obtain a BV24 families peak profile map; judging the distribution condition of the clone specific T lymphocytes in the peripheral blood according to the single peak appearance condition. The method of the invention can be used for detecting the clone specific T lymphocytes in infectious diseases, autoimmune diseases, tumors or transplantation rejections, evaluating the response of organisms to vaccines, etc.

Description

A kind of method that detects peripheral blood specific T lymphocyte

Technical field

The invention belongs to the biological medicine technology field, relate to molecular immunology and molecular biology, particularly a kind of detection method is specially a kind of method that detects peripheral blood specific T lymphocyte.

Background technology

(T cell receptor TCR) is the important molecule of identification of T lymphocytic cell surface and conjugated antigen, participation specific cellular immunity to TXi Baoshouti.The heterology dimer that the lymphocytic TCR of the T of normal people's peripheral blood 95% is made of by disulfide linkage two polypeptide chains of α, β.The α chain is reset and is formed by AV, AJ, AC in the germline gene, AV nucleotide sequence terminal and AJ front end and middle insertion has been formed TCR α chain variable region complementary determining region 3 (CDR3), the β chain is formed through rearrangement by the BV in the germline gene, BD, BJ, BC gene fragment, has wherein formed TCR β chain CDR3 by the nucleotide sequence that inserts between BV (β chain variable region) gene fragment end, BD gene fragment, BJ gene fragment front end and V-D and the D-J.Different T cell clones have different lengths or not homotactic TCR BV CDR3 genomic constitution, form the diversity of CDR3 gene spectral pattern, and the length in CDR3 district and sequence determine its structure, thus the specificity of decision TCR.A kind of CDR3 sequence is represented a T cell clone, with the most of clone of same MHC peptide complex bonded T cell, identical BV fragment and CDR3 length are arranged, the frequency of measuring the appearance of particular B V CDR3 sequence can reflect the degree of specific T cells clonal expansion can reflect the lymphocytic functional status of T under the various disease state well.Analyze virus (as HBV) and infect back relevant TCR CDR3 gene family specificity clonal expansion situation and TCR BV CDR3 genomic constitution, can consider to adopt specificity TCR CDR3 monoclonal antibody activation infected patient from body T cell, thereby the Specific CTL Cells that obtains clinical treatment quantity is used for the potential treatment of infectious diseases (hepatitis that causes as HBV); Also can separate the specificity TCR gene transfection to the corresponding disease after body or allogeneic peripheral blood lymphocyte are treated virus infection.

The method of analyzing TCR CDR3 has Southern blot, single strand conformation polymorphism (SSCP), denaturing gradient gel electrophoresis (DGGE), monoclonal antibody detection etc.Develop flow cytometer subsequently and detected the secretion that detects cytokine after cell within a cell factor expression or the antigenic stimulation of ELISpot binding specificity, can reflect the hypotype and the function of T cell indirectly.Along with the appearance of tetramer technology (tetramer), detect antigen-specific cytotoxic T cell (CTL) technology with tetramer and obtained very big development.But these methods can not provide the composition information of T cell in the TCR characterization of molecules of specific T-cells and the whole sample.

In recent years, immunoscanning spectral pattern analytical technology (immunoscope spectratyping) obtains using comparatively widely on the expression frequency of analyzing CDR3 and length distribution.Distinguish size according to the very high resolving power of finite concentration denaturing polyacrylamide gel (PAGE) and only differ the Ibp nucleotide fragments, then through genescan (GeneScan) analytical electrophoresis result.According to TCR CDR3 expression conditions, thereby infer body T cell clone amplification situation.Abroad, capillary electrophoresis technique is progressively used analyzing on the TCRBV, utilizes kapillary sequenator (ABI310) to detect aplastic anemia (AA) specificity TCR BV CDR3 gene spectral pattern characteristics as external someone.In recent years, real-time fluorescence quantitative PCR and melting curve analytical technology are detecting TCR BV family and are identifying on the T cell clone hyperplasia and also progressively used.

At present real time fluorescent quantitative (real time) round pcr is the nucleic acid molecule quantitative detecting method of generally acknowledge the most responsive, the most accurate, good reproducibility, has been widely used in the clinical detection of fundamental research and pathogenic agent.The principle of real-time fluorescence quantitative PCR technology is for adding fluorophor (molecule) in the PCR reaction system, by fluorescent signal increase the increase that comes the reaction dna amount in proportion, make the real-time detection of PCR product become possibility.Conventional relatively PCR, the major advantage of quantitative fluorescent PCR is to determine the number of copies of original template and high sensitivity in dynamicrange exactly.In addition, the result of quantitative fluorescent PCR need not to assess by agarose gel electrophoresis, can save experimental period, improves conventional efficient, reduces the probability that laboratory sample pollutes.

Real-time fluorescence quantitative PCR detection method mainly contains 2 kinds: a kind of hybridization probe that is to use, promptly when adding a pair of primer, pcr amplification adds a specific fluorescent probe, this probe is an oligonucleotide, and two ends are mark report fluorophor and a cancellation fluorophor respectively.When probe was complete, the reporter group fluorescent signal emitted was absorbed by quenching group; During pcr amplification, 5 '～3 ' 5 prime excision enzyme activity of Taq enzyme is cut degraded with the probe enzyme, the report fluorophor is separated with the cancellation fluorophor, the fluorescence monitoring system can receive fluorescent signal, be DNA chain of every amplification, just have a fluorescence molecule to form, realized that the accumulation of fluorescent signal and PCR product form fully synchronously, utilize the fluorescent signal accumulation whole PCR process of monitoring in real time, by typical curve unknown template is carried out quantitative analysis at last.Another kind is to use SYBR Green I dyestuff, compare with hybridization probe, SYBRGreen I does not need to design specific sequence, and its detection principle is: SYBR Green I is a kind of dyestuff that is incorporated into the double-stranded DNA ditch, maximum absorption wavelength is about 497nm, and maximum emission wavelength is about 520nm.SYBR Green I is with after double-stranded DNA combines, and its fluorescence intensity strengthens greatly.In the PCR reaction system, add excessive SYBR fluorescence dye, after the SYBR fluorescence dye mixes the dna double chain specifically, the emitting fluorescence signal, and do not mix in the chain SYBR dye molecule fluorescent signal extremely a little less than, thereby the increase that guarantees the increase of fluorescent signal and PCR product is synchronous fully.

Do not have specificity because of SYBR Green I combines with double-stranded DNA, be easy to generate the non-specific fluorescence signal, we carry out the melting curve analysis to the PCR product and distinguish specificity and non-specific product, and primer dimer.Promptly after the PCR reaction finishes, the PCR product is risen to 95 ℃ from certain beginning temperature by certain rate temperature change (Ramp), the amplified production double-stranded DNA unwinds into strand with temperature rising gradually changeable, the fluorescence dye SYBR green I that is embedded in the two strands discharges, fluorescent signal is decayed thereupon in the reaction system, the temperature variant melting curve of amplified production fluorescent signal (melting cuve) is drawn out in the variation of the automatic detection reaction inner fluorescent tube of instrument signal at last.Thereby the specificity of differentiation and non-specific amplification, thus SYBR GreenI be used for real-time quantitative detect convenient, economy, and can detect a plurality of genes in same system.In addition, (dF/dT) and between melting temperature (Tm) (Tm) map by the negative first order derivative that fluorescence signal intensity changes, obtain the melting curve peak shape figure of PCR product, we are referred to as gene fusion spectral type curve (Gene melting sepctratyping, GMST) (is the immunoscanning spectral type curve that the basis obtains through genescan because of this figure is similar to the gene fragment size).Because the melting temperature (Tm) of PCR product and product fragment are formed, size, base compositions etc. are relevant, therefore we can distinguish the fragment composition situation in the PCR product of mixing according to gene fusion spectral type curve, if it is unimodal, then represent in the PCR product fragment form single, if multimodal represents that then the PCR product is made up of a plurality of fragments, thereby learn clone's property amplification situation of specific gene, reflect body T cell function state.

In addition, the application of relation research between viral infection (as HBV) and the TCR CDR3 clone property hyperplasia, we can consider following several respects: (1) finds the subfamily with the comparatively closely-related specificity TCR CDR3 of a certain virus infection, inquires into the T lymphocyte from machine-processed aspect and takes place and developing variation in disease; (2) power of specific immune response behind TCR CDR3 family that the analysis virus infection is relevant and the organism infection, consider to adopt specific TCR CDR3 monoclonal antibody activation infected patient from body T cell, thereby the Specific CTL Cells of acquisition clinical treatment quantity is used for the potential treatment of corresponding virus infection associated diseases; (3) if the genomic constitution of known specificity TCR CDR3 can be used to transfection (tcr gene) and treats corresponding disease from body or allosome peripheral blood lymphocyte; (4) known clone-specific T CR molecular composition can help the evaluation that is used for the CTL epi-position and the design of HBV therapeutical peptide vaccine.The research of carrying out this respect can drive people theoretically from more profound understanding T cell and the effect of specificity TCR infectious diseases (virus, cell, parasite) thereof, also helps to design the polypeptide vaccine that is used for corresponding disease treatment.The detection method of clone-specific T cell also helps the effect of clear and definite T lymphocyte in tumour, autoimmune disease, transplant rejection etc. are fallen ill and worsened, and helps the Clinics and Practices of these diseases.

Summary of the invention

The purpose of this invention is to provide a kind of method that detects peripheral blood specific T lymphocyte, for the research infectious immunity relevant with TCR, autoimmune disorder, transplant rejection, tumour (hemopathy) etc. provide a good technology platform.

A kind of method that detects peripheral blood specific T lymphocyte of the present invention comprises the steps:

(1) the peripheral blood sample to be checked of preparation anti-freezing;

(2) density gradient centrifugation separates peripheral blood mononuclear cell (PBMC), total RNA among the test kit extracting PBMC, and adopt MBI company reverse transcription test kit reverse transcription to become cDNA;

(3) be respectively upstream primer with one of 26 primers of 24 families of TXi Baoshouti (TCR) beta chain variable region (BV), BV5 wherein, each 2 primer of BV13; BC1, the common downstream primer BC of BC2 zone design, the cDNA of step (2) preparation above dye method (SYBR GreenI) the real-time fluorescence quantitative PCR amplification peripheral blood;

(4) melting curve is analyzed the PCR product of cDNA, (dF/dT) and between temperature (Tm) map by PCR product fluorescence intensity being changed negative first order derivative, obtain the corresponding peak shape figure of each family of TCR BV 24 families, be referred to as gene fusion spectral type curve (GMST), to carrying out sequential analysis behind the PCR product purification that unimodal BV family only occurs, or with identical primer the PCR product is increased once more, go sequential analysis behind the gained PCR product purification again;

(5) distribute according to each BV family peak shape on the gene fusion spectral type curve, if a certain family of BV only occurs unimodal on GMST, show that then the T lymphocyte in this BV family is the specific monoclonal amplification, if all do not have unimodal appearance on each peak shape figure of family (GMST) of BV, then illustrate not have the amplification of T lymphocyte specific in the peripheral blood.

(6), can further distinguish T lymphocyte mono-clonal, few clone or polyclone amplification situation according to each family of peripheral blood T lymphocyte TCR BV peak shape diagram shape and distribution on GMST.

The described total RNA extraction reagent box of step (2) is selected OMEGA company product for use; The described real-time fluorescence quantitative PCR amplifing reagent of step (3) is selected the precious biotech firm (TAKARA) in Dalian test kit for use.

The reaction chamber temperature that the described melting curve of step (4) is analyzed slowly rises to 95 ℃ since 75 ℃ with 0.2 ℃/s rate temperature change, i.e. 0.2 ℃ of the every rising of the temperature of PCR product, and the 521nm wavelength detects fluorescent value simultaneously, and the hold-time is 2s.

The gene order of step (3) described downstream universal primer BC is as follows: 5 '-TTC TGA TGG CTC AAA CAC-3 '.

Description of drawings

Fig. 1: 10 routine chb (CHB) patient peripheral blood TCR BV, the 24 cDNA PCR of family products appear as unimodal BV family on gene fusion spectral pattern.

Fig. 2: 1 routine CHB patient TCR CDR3 transcript PCR product shows as the part fragment and the aminoacid sequence thereof of unimodal BV13.1 family sequencing result among Fig. 1 on gene fusion spectral type curve.Annotate: the aminoacid sequence of TCR CDR3 (band underscore) QTSVYFCASS YSGQGIDGYTFGSGTRLTVVE

Embodiment

Detailed implementation step of the present invention is as follows:

(1) preparation of PBMC: extract healthy blood donor's peripheral blood 5ml, with 1.9% Trisodium Citrate anti-freezing (1: 10), jog is after 1 minute, and room temperature left standstill 1 hour; Use phosphate buffered saline buffer (PBS) or RPMI-1640 substratum stoste with 1: 1 volume ratio mixing anticoagulation; Dilution blood is suspended from the interface of lymphocyte layering liquid (Shanghai permanent letter reagent company limited) of 5ml centrifugal 20 minutes of 400g; With suction pipe another centrifuge tube is put in cell taking-up in isolated middle layer (canescence), other goes into the PBS of 5 times of volumes, behind the abundant mixing, and centrifugal 10 minutes of 1500rpm; Abandon supernatant, wash once again with PBS.Obtain peripheral blood mononuclear cell (PBMC) and be used to extract total RNA, if can not extract at once, can be frozen in-75 ℃ of refrigerator short-terms.

(2) extracting of Total RNA: E.Z.N.A Total RNAKit system (OMEGA company) is adopted in the extraction of peripheral blood mononuclear cell (PBMC) total RNA, and the leaching process strictness is undertaken by the reagent specification sheets.The totalRNA of absorption on (bind) post be with no Rnase water elution at last, the total RNA of extraction or immediately reverse transcription become cDNA, or it is standby to be stored in-78 ℃ of refrigerators.The quality of RNA and content go up to be measured OD260/OD280 ratio at Spectrophotometer (bio-rad), get ratio and are 1.7～2.0 RNA sample and be used for subsequent experimental.

(3) cDNA is synthetic: getting the total RNA of about 1 μ g respectively is template, with Olig (dT) is primer, and the cDNA reaction system is 20 μ l, and every sample is done 3 reactions, press the synthetic cDNA of cDNA synthetic agent box (MBI company product) condition, step is as follows: each 0.2ml thin-walled PCR reaction tubes adds the about 1 μ g of total RNA, adds oligo (dT) 18 Primer (0.5 μ g/ml) 1 μ l, adds DEPC water to 12 μ l, mixing gently, 70 ℃, 5min places in the ice chest; Add 5 * buffer, 4 μ l, add Inhibitor (20u/ μ l) 1 μ l, add 10mM dNTP 2 μ l, mixing gently, 37 ℃, 5min; Add RvertAid ^TMHMinus M-MuL V (200u/ μ l) 1 μ l, cumulative volume 20 μ l, 42 ℃, 60min, 70 ℃, 10min places in the ice chest.

(4) primer is synthetic: according to bibliographical information and people's tcr gene storehouse, and synthetic 26 of 24 family's upstream primers of TCR BV gene (wherein BV5, BV13 respectively have two primers); One of shared downstream primer BC, latter's nucleotide sequence is as follows: 5 '-TTCTGATGG CTC AAA CAC-3 '.

(5) cDNA of each CDR3 of family of fluorescent quantitative PCR BV: comprise 1 μ l cDNA sample in per 20 μ l PCR reaction systems and (contain one of 26 upstream primers (BV1～24) that are equivalent to total RNA amount 10～50ng) and each 0.3 μ mol/L, downstream primer (BC), add 2 * SYBR Real time PCR Master Mix premix, 10 μ l, tri-distilled water is supplied 20 μ l reaction systems, the PCR reaction conditions is as follows: 94 ℃ of pre-sex change 3 minutes, 94 ℃ 20 seconds, annealing temperature be made as 56 ℃ 30 seconds, 72 ℃ of elongating temperatures 30 seconds, totally 45 circulations.After each loop ends, the 521nm wavelength is read plate (measuring every hole fluorescence intensity) after 80 ℃ of temperature kept for 2 seconds, and last 72 ℃ were extended 8 minutes.

(6) the melting curve analysis of real-time fluorescence quantitative PCR product: after the PCR response procedures finishes, reaction chamber temperature slowly rises to 95 ℃ since 75 ℃ with 0.2 ℃/s rate temperature change, be 0.2 ℃ of the every rising of temperature of PCR product, the 521nm wavelength detects fluorescent value simultaneously, and the hold-time is 2s.

(7) melting curve is analyzed the PCR product: PCR product fluorescence intensity is changed negative first order derivative (dF/dT) and between temperature (Tm) map, obtain the peak shape figure of each family of BV, be referred to as gene fusion spectral type curve (GMST).Gene fusion spectral type curve according to each family of BV can be judged T lymphocyte clone amplification situation, if a certain family only occurs unimodal, the T lymphocyte that this BV family is described is the mono-clonal amplification, if on the peak shape figure a plurality of peaks are arranged, and no more than 4 peaks, then be indicated as few clonal expansion,, show that then polyclone T cell exists in this BV family if the peak shape figure of a BV family is multimodal (more than 4 peaks).Carry out sequencing behind the PCR product purification of the BV family of unimodal to only occurring (amplification of clone's property), standard TCR BV, BD, BJ, BC sequence are compared (BLAST) in sequencing result and DDBJ, GeneBank and the IMGT storehouse, determine the T cell TCR CDR3 genomic constitution of specificity clonal expansion.

Advantage of the present invention and application prospect

TXi Baoshouti (TCR) beta chain variable region (BV) CDR3 gene spectral pattern detects, and method in the past mostly is to infer clone's property propagation of T cell indirectly by the obvious increase of the PCR product of some pedigree of half-quantitative detection TCR CDR3.

In recent years, design the upstream primer of each family respectively according to the cDNA sequence of 32 families of 24 gene families of V β and V α, from C β 1 and common downstream primer of C β of C β 2 zone design, each sample carries out 26 (BV5 of V β respectively, BV13 respectively has two subfamilies), 32 pcr amplifications of V α, by the genescan of amplified production being judged T cell clone propagation, as mono-clonal or few clone's product appear, then further separation and purification, carry out dna sequence analysis, understand the nucleotide sequence composition situation of its CDR3 etc., thereby can know the genomic constitution of TCR, be called immunoscanning spectral pattern analytical technology.But operation is comparatively complicated during the lymphocytic tcr gene spectral pattern of this technical Analysis T feature (TCR α chain and TCR β chain CDR3 gene), and crossed contamination easily.Use that dye method (SYBR Green I) real-time fluorescence quantitative PCR technology and melting curve analysis are increased to the transcript cDNA of peripheral blood TCR BV CDR3 gene mRNA and the melting curve analysis detects the amplification of T cell clone.Thereby the complicated processes in the time of can avoiding polyacrylamide gel electrophoresis (PAGE) analyzing DNA clip size has also embodied dye method (SYBR Green I) fluorescent quantitative PCR technique is easy and simple to handle, repeatability is high, crossed contamination is few and advantage such as expense is low.This technology provides a good technology platform for the research infectious immunity relevant with TCR, autoimmune disorder, transplant rejection, tumour (hemopathy) etc.The melting curve analytical technology can be looked for specificity clone T cell easily in these T cell related diseases, thereby helps the diagnosis of disease, has also shortened the operating time greatly.

Research aircraft peripheral body T cell clone amplification situation, can further understand the effect of T lymphocyte in corresponding disease incidence mechanism, detected TCR CDR3 sequence, might treat corresponding disease by transgenosis (specificity TCR gene), also help to develop therapeutic vaccine based on the TCR epitope polypeptide.

Application example: the detection of chb patient peripheral blood lymphocyte TXi Baoshouti BV CDR3

Present embodiment is to detect chb patient peripheral blood specific T-cells clone property amplification situation

(hepatitis B virus HBV) classifies as first of the ten big causes of death of the whole world, and HBV the infected in whole world estimates to surpass 4.0 hundred million hepatitis B virus in The World Health Organization (WHO).Wherein have at least 20%～30% HBV surface antigen (HBsAg) carrier finally will die from chronic viral hepatitis B (Chronic B Hepatitis, CHB) relative disease (liver cirrhosis, liver cancer).China is the high popular area that HBV infects.According to national HBV infected person anteserum epidemiology survey in 2002, China HBsAg prevalence rate was 9.09%, about 1.2 hundred million people, and wherein the chb patient is about 2,000 ten thousand～3,000 ten thousand.In the natural history in 5 years of chronic hepatitis B, about 10%～20% chb can develop into liver cirrhosis, and 20%～23% liver cirrhosis can develop into and lose the compensatory liver cirrhosis, and 6%～15% chb can develop into hepatocellular carcinoma (HCC).In the chb patient, about 25%～40% finally will die from liver cirrhosis or liver cancer, surpass the world average level.The expense that the whole nation is used for hepatitis B and treating correlative diseases thereof every year is hundreds of millions of, has consumed a large amount of medical resources, but a lot of patient still dies from liver failure, liver cancer.Though liver transplantation is the fine means of treatment hepatopathy in whole latter stage, because the extremely shortage in liver source, a lot of patients die in wait.Therefore develop clinically that new method is monitored disease progression even treatment chronic hepatitis B (CHB) has realistic meaning very much.

After HBV infected, the principal element that the decision course of disease lapses to was the immune response ability, especially specific cytotoxic T lymphocyte (cytotoxic T lymphocyte, reaction level CTL).After HBV infected body, the activatory specific CTL suppressed virus replication by the non-molten cell mechanism that kills and wounds target cell and secrete cytokines in the body.As discover at acute HBV and infect final the removing in the viral individuality, the ctl response that occurs at HBV in its body is polyclone, polyspecific, but at chronically infected individuality, specific ctl response is very weak, be difficult to be detected, body develops into a kind of immune tolerance state to HBV, makes the HBV infection continue to exist and make state of an illness chronicity.Ahmed R etc. points out the power of the t cell immune response of antivirus action, is likely decision HBV the infected's incidence.Wherein, as main effector cell, it is directly relevant with damaging cells to participate in removing virus at the specific CTL of the various epitopes of HBV.Someone is to showing after the relation research between HBV chronic infection person and human peripheral lymphocytes function status, chronic HBV infection person periphery blood T cell function does not significantly change, be T cell surface receptor (T cell receptor, TCR) change, illustrate that TCR plays an important role in the HBV chronic infection person course of disease, the genomic constitution that therefore detects clone-specific T cell and TCR BV CDR3 has great importance in research chb patient's morbidity, deterioration and diagnosis and treatment thereof.

1. chb patient's diagnosis and source

Chb (CHB) group 10 examples, the male sex's 6 examples, women's 4 examples, age 21-50 (41.3 ± 7.6y), be the CHB patient that is in hospital in December, 2006 of my institute, diagnosis meets in December, 2005 China's medical association's hepatopathy credit meeting and infects " prevention and treatment for chronic hepatitis B guide " standard that formulation is united in sick credit meeting.All patients are except that HBV infects, and other known pathogen antigen detects all negative, no tumour and immunological disease, and in nearly 6 months, do not use immunomodulator or antiviral therapy.

2. the detection of peripheral blood clone property amplification T

Chb patient peripheral blood PBMC separates, the extracting of total RNA, cDNA are synthetic, quantitative fluorescent PCR operation, the analysis of gene melting curve be with top step.On gene fusion spectral type curve (GMST), only occurring carrying out sequencing behind the unimodal PCR product purification.Tcr gene on sequencing result and the Genebank is compared, thus the genomic constitution of definite chb patient periphery blood T cell clone property amplification situation and T cell TCR CDR3.

Occur the BV family of unimodal figure in the gene fusion spectral type curve of 24 BV families of chb patient, see Fig. 1～2.Unimodal figure shows that the CDR3 transcription PCR product composition of BV family is single, illustrate that this CDR3 may be from single T cell clone, we check order to this PCR product, are indicated as monospecific polyclonal (only listing the sequencing result of a sample), further illustrate result's accuracy.In clone's property amplification situation of 10 routine chb patient peripheral blood TCR BV, 24 families in the present embodiment, we send out the several families of patient existing and show as the mono-clonal amplification, there are several routine patients clone's property amplification of identical BV family to occur, also need further research as for wherein reason.

Sequence table

The gene order of downstream universal primer BC: 5 '-TTCTGATGGC TCAAACAC-3 '

The aminoacid sequence (band underscore) of 1 routine CHB patient's clone-specific BV 13.1 TCR CDR3 of family: QTSVYFCASS YSGQGIDGYTFGSGTRLTVV E

Claims (4)

1. method that detects peripheral blood specific T lymphocyte, described method comprises the steps:

(1) the peripheral blood sample to be checked of preparation anti-freezing;

(2) density gradient centrifugation separates peripheral blood mononuclear cell (PBMC), total RNA among the test kit extracting PBMC, and adopt MBI company reverse transcription test kit reverse transcription to become cDNA;

(3) 26 primers with 24 families of TXi Baoshouti (TCR) beta chain variable region (BV) are respectively upstream primer, BV5 wherein, and BV13 respectively is provided with 2 upstream primers; BC1, the common downstream primer BC of BC2 zone design, above the cDNA of step (2) preparation be template, dye method (SYBR Green I) real-time fluorescence quantitative PCR increases;

(4) melting curve is analyzed the PCR product of cDNA, (dF/dT) and between temperature (Tm) map by PCR product fluorescence intensity being changed negative first order derivative, obtain the corresponding peak shape figure of each family of TCR BV 24 families, be referred to as gene fusion spectral type curve (Genemelting spectratyping, GMST);

(5) distribute according to each BV family peak shape on the gene fusion spectral type curve, if a certain family only occurs unimodal on GMST, show that then the T lymphocyte in this BV family is the specific monoclonal amplification, all do not have unimodal figure appearance if GMST goes up each family of BV, then illustrate not have the amplification of T lymphocyte specific in the peripheral blood.

2. method as claimed in claim 1 is characterized in that: the described total RNA extraction reagent box of step (2) is selected from OMEGA company; The precious biotech firm (TAKARA) in Dalian test kit is selected in the described real-time fluorescence quantitative PCR amplification of step (3) for use.

3. method as claimed in claim 1, the reaction chamber temperature that the described melting curve of step (4) is analyzed slowly rises to 95 ℃ since 75 ℃ with 0.2 ℃/s temperature ascending rate (ramp), it is 0.2 ℃ of the every rising of temperature of PCR product, the 521nm wavelength detects fluorescent value simultaneously, and the hold-time, (hold time) was 2s.

4. method as claimed in claim 1, the gene order of the described common downstream primer BC of step (3) is as follows: 5 '-TTC TGA TGGCTC AAA CAC-3 '.

Images